The Goldman Sachs Group Lowers Revvity (NYSE:RVTY) Price Target to $95.00

Key Points

• Goldman Sachs cut Revvity's price target from $110 to $95 and kept a "neutral" rating, implying only about a 0.92% upside from the prior close.
• Revvity beat quarterly estimates with $1.70 EPS (vs. $1.55 expected) and $772.1M revenue, and set FY2026 guidance of 5.350–5.450 EPS compared with analysts' ~4.94 EPS estimate.
• The stock's consensus remains a "Hold" (4 Buy, 9 Hold, 1 Sell) with a market consensus target of $110.17, creating a divergence between the firm-wide average target and Goldman Sachs' lower view.

Revvity (NYSE:RVTY - Get Free Report) had its price objective decreased by equities research analysts at The Goldman Sachs Group from $110.00 to $95.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. The Goldman Sachs Group's target price points to a potential upside of 0.92% from the company's previous close.

A number of other research firms have also recently commented on RVTY. Jefferies Financial Group boosted their target price on shares of Revvity from $100.00 to $105.00 and gave the stock a "hold" rating in a research report on Monday, February 2nd. Robert W. Baird set a $129.00 target price on shares of Revvity in a research report on Tuesday, February 3rd. TD Cowen reissued a "hold" rating on shares of Revvity in a research report on Tuesday, February 3rd. Weiss Ratings cut shares of Revvity from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, March 18th. Finally, Evercore boosted their target price on shares of Revvity from $112.00 to $118.00 and gave the stock an "outperform" rating in a research report on Tuesday, February 3rd. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $110.17.

Revvity Trading Up 1.6%

RVTY traded up $1.49 during trading on Tuesday, hitting $94.13. 169,768 shares of the company's stock were exchanged, compared to its average volume of 1,264,147. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. Revvity has a 1 year low of $81.36 and a 1 year high of $118.30. The stock has a 50 day moving average price of $92.93 and a 200 day moving average price of $96.86. The firm has a market cap of $10.52 billion, a P/E ratio of 45.26, a price-to-earnings-growth ratio of 1.91 and a beta of 1.13.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The company had revenue of $772.06 million during the quarter, compared to the consensus estimate of $759.81 million. During the same period in the previous year, the firm earned $1.42 earnings per share. Revvity's revenue for the quarter was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. As a group, analysts expect that Revvity will post 4.94 EPS for the current fiscal year.

Institutional Trading of Revvity

Institutional investors have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD raised its holdings in shares of Revvity by 5.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company's stock worth $832,693,000 after purchasing an additional 434,570 shares during the period. EdgePoint Investment Group Inc. raised its holdings in shares of Revvity by 26.3% during the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company's stock worth $751,536,000 after purchasing an additional 1,784,620 shares during the period. Janus Henderson Group PLC raised its holdings in shares of Revvity by 7.0% during the fourth quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company's stock worth $789,595,000 after purchasing an additional 533,912 shares during the period. Morgan Stanley raised its holdings in shares of Revvity by 29.6% during the fourth quarter. Morgan Stanley now owns 2,844,464 shares of the company's stock worth $275,202,000 after purchasing an additional 650,083 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Revvity by 22.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,612,116 shares of the company's stock worth $252,727,000 after purchasing an additional 486,159 shares during the period. 86.65% of the stock is owned by institutional investors and hedge funds.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.